MPM RadiaPlex®Rx
OraMagic®Rx Oral Wound Rinse
OraMagic® Plus Oral Wound Rinse
CoolMagicTM Gel Sheets
Regenecare® Wound Gel

Regenecare®HA Wound Gel

Regenecare®HA Saturated Pads
 
 

MPM CoolMagicTM Gel Sheets is excellent for reducing the pain from burns and skin reactions to radiation, cuts burns and abrasions.



"The Regenecare products are the first evidenced based wound and skin care products that provide local analgesia to control pain between dressing changes."


"With the addition of Hyaluronic Acid, Regenecare®HA Gel provides greater moisture to the wound while reducing pain caused by debridement."
| | | |
 

 

MPM Regenecare® Wound Gel (with Lidocaine)
A Pain Relieving Hydrogel

 

 Reduces pain caused by radiation
Reduces side effects caused by epidermal growth factor receptors such as rash and itching
For the management of: Pressure Ulcers Stage I – IV, First & Second Degree Burns, Stasis Ulcers
Facilitates Moist Wound Environment
Major Ingredients:
 

Lidocaine HCI - 2% Topical Anesthetic
Collagen - an excellent hemostatic agent is made up of chains of amino acids that form fibrils producing fibers that lead to tissue formation.
Aloe Vera - promotes a moist wound environment.


* Prescription needed


 

 

MPM Regenecare® Wound Gel (with Lidocaine)
Product#
NDC#
Size
Pkg.
MP00100
66977-100-03
3 oz. Tube
12 /Case
MP00101
66977-100-05
1/2 oz. Tube
12 /Case

 

Download MSDS

5. A pilot crossover study to evaluate the use of Regenecare topical wound gel in patients with cutaneous toxicity caused by epidermal growth factor receptor (HER1/EGFR) inhibitors.
Citation: Journal of Clinical Oncology, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 19643
Author(s): S. Wong, K. E. Osann, K. P. Lloyd, C. M. Vasko, R. L. Arcinas, M. Mummaneni
Click here to read the supportive case trial listed at National Cancer Institute (www.cancer.gov)

6. A Pilot Cross-Over study to evaluate the use of Regenecare® topical gel in patients with cutaneous toxicity caused by epidermal growth factor receptor (HER1/EGFR) inhibitors. SF Wong, Pharm D. K Lloyd MS, C Vasko RN, OCN, NP, M Mummaneni M.D., K Osann PhD. Presented at 9th National Conference on Cancer Nursing Research, 2007, 126, Oncology Nursing Forum, 2007, 34:1:216-217. Published study Click here to read the supportive case trial listed at National Cancer Institute (www.cancer.gov)

7. Evaluation of Regenecare® Topical Gel in the Treatment of Skin Rash Associated with Cetuximab (Erbitux®), Tarceva® and Other EGFR Inhibitors-Treated Cancer Patients. M. Kozloff, M.D., PA Gowland, RN, BSN, OCN, CCRC, J Vlamakis RN, OCN, J Koch RN BSN, G Ratko RN, BSN, L Gravitt RN, OCN, D Palmer CCRP, Ingalls Memorial Hospital, Cancer Research Center. Harvey Ill., 2007.

8. Evaluation of Cutaneous Skin Rash in Subjects Treated with Regenecare® Topical Gel (Collagen, Aloe vera, & 2% Lidocaine) During Erbitux® and Combination Therapies for Cancer. SF Wong, Pharm D, Western University of Health Sciences, College of Pharmacy, Pamona CA, Faculty in Residence Hematology Oncology Medical Group of Orange County, CA, Nov. 2006.

9. Case Studies Evaluating Regenecare® Topical Gel, with 2% Lidocaine HCl, Collagen & Aloe Vera for Treating Cutaneous Rash Associated with EGFR (HER!/EGFR) Inhibitors. S F Wong, Pharm D, Western University of Health Sciences, College of Pharmacy, Pamona CA, Faculty in Residence Hematology Oncology Medical Group of Orange County, Orange CA, Nov. 2006.

10. Regenecare® with Lidocaine Has Been Used Successfully on Over 400 Patients by Southwest Regional Wound Care Center, Lubbock, Texas to Anesthetize Wounds Prior to Debridement. Randall Wolcott M.D., P.A., American Professional Wound Care Association, 2006.

11. Evaluation of Tropical Gel(With 2% Lidocaine-HCI) for Treatment of Adverse Rash Sympotoms Associated With EGFR/HER1 Inhibitors
M.F.Kozloff, P.A. Gowland, J.Vlamakis, J.Koch, K.P.Lloyd, J.B.Spalding
Ingalls Memorial Hospital, Cancer Research Center, Harvey, Illinois; MPM Medical Inc., Irving, Texas; University of North Texas, Denton, Texas Published study

 

 

Address: 2301 Crown Ct, Irving TX 75038
Telephone: (972)893-4090 Fax: (972)893-4092

 

©Copyright 2007 MPM Medical, Inc.
MPM Medical, Inc. is a wholly owned subsidiary of RBC Life Sciences, Inc.